References
Crevenna R, Ashbury FD (2018) Physical interventions for patients suffering from chemotherapy-induced polyneuropathy. Support Care Cancer 26(4):1017–1018
Vallance JK, Bolam KA (2018) Letter to the editor-comments on Kleckner et al. (2018) “Effects of exercise during chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial”. Support Care Cancer. https://doi.org/10.1007/s00520-018-4361-4
Crevenna R, Keilani M (2018) Chemotherapy-induced peripheral neuropathy-more high-quality research is needed. Support Care Cancer. https://doi.org/10.1007/s00520-018-4371-2
Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM (2018) Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 26(4):1019–1028
Gewandter JS, Dworkin RH, Turk DC, McDermott MP, Baron R, Gastonguay MR, Gilron I, Katz NP, Mehta C, Raja SN, Senn S, Taylor C, Cowan P, Desjardins P, Dimitrova R, Dionne R, Farrar JT, Hewitt DJ, Iyengar S, Jay GW, Kalso E, Kerns RD, Leff R, Leong M, Petersen KL, Ravina BM, Rauschkolb C, Rice ASC, Rowbotham MC, Sampaio C, Sindrup SH, Stauffer JW, Steigerwald I, Stewart J, Tobias J, Treede RD, Wallace M, White RE (2014) Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations. Pain 155(9):1683–1695
Kraemer HC, Morgan GA, Leech NL et al (2003) Measures of clinical significance. J Am Acad Child Adolesc Psychiatry 42(12):1524–1529
Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A, le-Lindqwister NA, Soori GS, Jaslowski AJ, Novotny PJ, Lachance DH (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29(11):1472–1478
Majithia N, Temkin SM, Ruddy KJ, Beutler AS, Hershman DL, Loprinzi CL (2016) National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons. Support Care Cancer 24(3):1439–1447
Gewandter JS, Freeman R, Kitt RA, Cavaletti G, Gauthier LR, McDermott MP, Mohile NA, Mohlie SG, Smith AG, Tejani MA, Turk DC, Dworkin RH (2017) Chemotherapy-induced peripheral neuropathy clinical trials: review and recommendations. Neurology 89(8):859–869
Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C, Lin PJ, Mustian KM (2018) Exercise for toxicity management in cancer-a narrative review. Oncol Hematol Rev 14(1):28–37
Funding
Funding from the National Cancer Institute, including K07 CA221931 to I.R.K, NCORP parent grant U10 CA037420, and NCORP supplement U10 CA037420.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Several authors (I.R.K., C.K., M.C.J, and K.M.M.) received funding from the National Cancer Institute to support this work. J.S.G. received funding from Mundipharma and Regenacy Pharmaceuticals for other work (i.e., not this manuscript). The authors have full control of all primary data and agree to allow the journal to review the data if requested.
Rights and permissions
About this article
Cite this article
Kleckner, I.R., Kamen, C., Gewandter, J.S. et al. Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy. Support Care Cancer 27, 7–8 (2019). https://doi.org/10.1007/s00520-018-4528-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-018-4528-z